Replies to post #146871 on Biotech Values

[BTH]

CLDX

As of June 30, 2012, Celldex had approximately 58.8 million shares outstanding.

Even if they floated an additional 15 million (to raise ~$100 million), that is still far well below the outstanding shares of 75% biotechs I follow.

I'd be fine with that.

I just don't want them to sign on shitty terms for '011.